Annie Thériault, Managing Partner at CBIV, has been immersed in impact investing, venture capital, royalty financing, and capital markets throughout her career. As a venture capital investor and venture advisor, she worked with high impact companies to mobilize more than $100 million in non-dilutive capital. Annie was previously a director on the boards of several North American venture-backed companies, is an advisor to crowdfunding fintech company FrontFundr, and, prior to the launch of CBIV, was Chief Investment Officer at Grand Challenges Canada. Annie obtained her PhD in Management from the Rotman School of Management at the University of Toronto, is a CFA Charterholder, and holds the ICD.D designation. She also has a master’s degree in Business Economics from Wilfrid Laurier University and a Bachelor of Science with First Class Honours in Chemistry from Mount Allison University.

Donna Parr, Managing Partner at CBIV, has more than 30 years of experience managing venture capital, growth equity, and private debt investment portfolios of up to $1 billion. She has managed two biotech related funds (GrowthWorks Canadian Fund and Canadian Medical Discoveries Fund) and has held roles at several notable pension funds and firms, including OMERS, CPP, and TD Capital. She is currently on the boards of Constellation Software and Topicus.com. Donna holds a master’s degree in International Relations from the University of Toronto and earned her MBA from Schulich School of Business. She holds the ICD.D designation.

Cyriac Alappat, Principal at CBIV, brings to the team expertise in global health, international partnership networks, early-stage growth and financing as well as organizational behavior. Cyriac was part of the founding team of CBIV. Prior to the launch of the firm, he was an investment manager for the Every Woman Every Child Innovation Marketplace at Grand Challenges Canada, a highly successful platform that supported the fundraising efforts of a portfolio of over 40 early-stage high impact health companies based in North America, Africa and India towards mobilizing $46M in equity and non-dilutive financing. Cyriac often brings the view of the founder to the table, having joined Grand Challenges Canada, after a number of years operating a FinTech company he co-founded to accelerate the angel investment process and scaling in the MENA region. Cyriac started his career at an executive recruiting firm after obtaining his Chartered Accountant (CPA, CA) designation as part of the audit practice of E&Y. Cyriac earned a Bachelor’s Degree in Business Administration from Wilfrid Laurier University.

Megan Dover, Principal at CBIV, has more than 14 years of experience in impact investing, venture advisory, M&A, business strategy, Financial Planning & Analysis and angel investing. Megan was part of the founding team of CBIV. Prior to the launch of the firm, she was an investment manager for the Every Woman Every Child Innovation Marketplace at Grand Challenges Canada, a highly successful platform that supported the fundraising efforts of a portfolio of over 40 early-stage high impact health companies based in North America, Africa and India towards mobilizing $46M in equity and non-dilutive financing. Megan brought expertise in a number of areas to the role, having previously held roles in finance and strategy for a public resource company, worked in management consulting for a global consulting firm, been part of an R&D team for a biotech startup and as an advisor and angel investor at the Creative Destruction Lab (CDL). Megan obtained her MBA from the Rotman School of Management at the University of Toronto, receiving a Dean’s list ranking. She also earned her Engineering degree with Honours from Queen’s University, specializing in Biomedical Research within Chemical Engineering.

Expertise in senior academic administration, biomedical research, clinical care and medical education coupled with experience in the FDA regulatory environment including clinical trial protocols, drug and device approvals, data analysis and interpretation, drug labeling, increasing diversity in clinical trials, program impact and outcomes assessment, health policy and FDA guidance development.

Professor of Emergency Medicine at The Warren Alpert Medical School of Brown University and the Co-Founder and Director for the Division of Sex and Gender in Emergency Medicine (SGEM). Her research on the roles sex and gender have in emergent conditions includes over 60 peer reviewed publications and has made her a spokesperson and advocate for women around the world.

Dr. McGregor is a Co-Founder and Past Vice Chair of the national organization Sex and Gender Women’s Health Collaborative, whose purpose is to foster a sex and gender approach to education and clinical practice.

Robert Harding Chair in Global Child Health and Policy at Center for Global Child Health, Hospital for Sick Children

I am an obstetrician gynecologist with more than 20 years of experience in designing
and implementing multi-country clinical trials for the development and evaluation of health
interventions and technologies, assessing global health unmet needs and developing, monitoring
and evaluating health policies and initiatives at global, regional and country level. I have
extensive expertise in medical affairs within industry settings, including fostering and developing innovative technology, designing and implementing clinical evidence generation plans, conducting systematic reviews of the literature and risk management activities and assuring compliance with good clinical practices and safety policies and procedures.